Qlife Holding AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLIFE.ST research report →
Companywww.qlifeholding.com
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo. Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus.
- CEO
- Thomas Warthoe
- IPO
- 2020
- Employees
- 3
- HQ
- Helsingborg, SE
Price Chart
Valuation
- Market Cap
- $24.71M
- P/E
- -1.23
- P/S
- 75.34
- P/B
- -3.33
- EV/EBITDA
- -1.75
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2771.65%
- Op Margin
- -5930.79%
- Net Margin
- -6217.07%
- ROE
- 437.24%
- ROIC
- -1868.68%
Growth & Income
- Revenue
- $324.00K · 548.00%
- Net Income
- $-20,558,000 · 63.28%
- EPS
- $-1.64 · -382.35%
- Op Income
- $-19,384,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $5.74
- 52W Low
- $1.21
- 50D MA
- $1.97
- 200D MA
- $2.34
- Beta
- 0.24
- Avg Volume
- 53.04K
Get TickerSpark's AI analysis on QLIFE.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QLIFE.ST Coverage
We haven't published any research on QLIFE.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QLIFE.ST Report →